Enhertu User Reviews & Ratings (Page 2)
Enhertu has an average rating of 8.0 out of 10 from a total of 29 reviews on Drugs.com. 70% of reviewers reported a positive experience, while 3% reported a negative experience.
Reviews for Enhertu
- ALP...
- Taken for 1 to 6 months
- October 18, 2024
For Breast Cancer "So far, things have been going well, very few side effects, and my cancer seems to be under control."
- Jan...
- Taken for 1 to 6 months
- March 19, 2024
For Breast Cancer "Only 2 infusions, on Zofran and dexamethasone, caused severe constipation and cramps. Tumor markers next, only 2 infusions."
Frequently asked questions
- What is the success rate of Enhertu in metastatic breast cancer?
- Is Enhertu a chemotherapy drug? What's Enhertu used for?
- KUM...
- Taken for 1 to 2 years
- March 30, 2024
For Breast Cancer "True and Best Injection for HER2-POSITIVE Treatment."
- Ano...
- Taken for 6 months to 1 year
- May 4, 2025
"My CA125 numbers have decreased drastically. I am feeling better than I have for a while. I am having minor nose bleeding almost every day. Occasional muscle cramps sometimes in unusual places, like mid back or upper arm, almost daily on my right calf. They are short-term but mildly painful. Joint pain, usually short-term."
Are you taking this medicine?
Your review helps others make informed decisions.More about Enhertu (fam-trastuzumab deruxtecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
For Breast Cancer "It is saving my life & has limited side effects. While I am on it, my tumor did not spread or grow."